Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses

Cancer remains the second most common cause of death worldwide affecting around 10 million patients every year. Among the therapeutic options, chemotherapeutic drugs are widely used but often associated with side effects. In addition, toxicity against immune cells may hamper anti-tumor immune respon...

Full description

Bibliographic Details
Main Authors: Allan Scarpitta, Ulrich T. Hacker, Hildegard Büning, Olivier Boyer, Sahil Adriouch
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.731598/full
_version_ 1818694140434579456
author Allan Scarpitta
Ulrich T. Hacker
Hildegard Büning
Hildegard Büning
Olivier Boyer
Olivier Boyer
Sahil Adriouch
author_facet Allan Scarpitta
Ulrich T. Hacker
Hildegard Büning
Hildegard Büning
Olivier Boyer
Olivier Boyer
Sahil Adriouch
author_sort Allan Scarpitta
collection DOAJ
description Cancer remains the second most common cause of death worldwide affecting around 10 million patients every year. Among the therapeutic options, chemotherapeutic drugs are widely used but often associated with side effects. In addition, toxicity against immune cells may hamper anti-tumor immune responses. Some chemotherapeutic drugs, however, preserve immune functions and some can even stimulate anti-tumor immune responses through the induction of immunogenic cell death (ICD) rather than apoptosis. ICD stimulates the immune system by several mechanisms including the release of damage-associated molecular patterns (DAMPs) from dying cells. In this review, we will discuss the consequences of inducing two recently characterized forms of ICD, i.e., pyroptosis and necroptosis, in the tumor microenvironment (TME) and the perspectives they may offer to increase the immunogenicity of the so-called cold tumors and to stimulate effective anti-tumor immune responses.
first_indexed 2024-12-17T13:24:51Z
format Article
id doaj.art-92d156eaea2e41a3abe500f63393b19e
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T13:24:51Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-92d156eaea2e41a3abe500f63393b19e2022-12-21T21:46:46ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.731598731598Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune ResponsesAllan Scarpitta0Ulrich T. Hacker1Hildegard Büning2Hildegard Büning3Olivier Boyer4Olivier Boyer5Sahil Adriouch6UNIROUEN, INSERM, U1234, Pathophysiology, Autoimmunity, Neuromuscular Diseases and Regenerative Therapies, Normandie University, Rouen, FranceDepartment of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center Leipzig (UCCL), University of Leipzig Medical Center, Leipzig, GermanyInstitute of Experimental Hematology, Hannover Medical School, Hannover, GermanyREBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, GermanyUNIROUEN, INSERM, U1234, Pathophysiology, Autoimmunity, Neuromuscular Diseases and Regenerative Therapies, Normandie University, Rouen, FranceDepartment of Immunology and Biotherapy, Rouen University Hospital, Rouen, FranceUNIROUEN, INSERM, U1234, Pathophysiology, Autoimmunity, Neuromuscular Diseases and Regenerative Therapies, Normandie University, Rouen, FranceCancer remains the second most common cause of death worldwide affecting around 10 million patients every year. Among the therapeutic options, chemotherapeutic drugs are widely used but often associated with side effects. In addition, toxicity against immune cells may hamper anti-tumor immune responses. Some chemotherapeutic drugs, however, preserve immune functions and some can even stimulate anti-tumor immune responses through the induction of immunogenic cell death (ICD) rather than apoptosis. ICD stimulates the immune system by several mechanisms including the release of damage-associated molecular patterns (DAMPs) from dying cells. In this review, we will discuss the consequences of inducing two recently characterized forms of ICD, i.e., pyroptosis and necroptosis, in the tumor microenvironment (TME) and the perspectives they may offer to increase the immunogenicity of the so-called cold tumors and to stimulate effective anti-tumor immune responses.https://www.frontiersin.org/articles/10.3389/fonc.2021.731598/fullimmunogenic cell death and anti-tumor immunitypyroptosisnecroptosisanti-tumor immune responsestumor immune microenvironmentinflammation and immunity
spellingShingle Allan Scarpitta
Ulrich T. Hacker
Hildegard Büning
Hildegard Büning
Olivier Boyer
Olivier Boyer
Sahil Adriouch
Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
Frontiers in Oncology
immunogenic cell death and anti-tumor immunity
pyroptosis
necroptosis
anti-tumor immune responses
tumor immune microenvironment
inflammation and immunity
title Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
title_full Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
title_fullStr Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
title_full_unstemmed Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
title_short Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
title_sort pyroptotic and necroptotic cell death in the tumor microenvironment and their potential to stimulate anti tumor immune responses
topic immunogenic cell death and anti-tumor immunity
pyroptosis
necroptosis
anti-tumor immune responses
tumor immune microenvironment
inflammation and immunity
url https://www.frontiersin.org/articles/10.3389/fonc.2021.731598/full
work_keys_str_mv AT allanscarpitta pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT ulrichthacker pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT hildegardbuning pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT hildegardbuning pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT olivierboyer pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT olivierboyer pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses
AT sahiladriouch pyroptoticandnecroptoticcelldeathinthetumormicroenvironmentandtheirpotentialtostimulateantitumorimmuneresponses